EUVIMEDEUVIMED entdecken
Open Access

The melanocytic transcriptomic state is independently associated with poor overall survival in patients with metastatic melanoma

Ziyin Huang iD, Kristen E Rhodin iD, Rami Al-Rohil iD, Viviana Geron iD, Arul M Chinnaiyan iD, Margaret H O'Connor iD, Christina V Angeles iD, Smita K Nair iD, Matthew K Iyer iD, Georgia M Beasley iD

Science Advances · 24.07.2026 · 12 (30)

DOI: 10.1126/sciadv.aec7394 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 24.07.2026. Verfasst von Ziyin Huang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA. Hauptthemen laut MEDLINE: Melanoma, Transcriptome, Melanocytes, Skin Neoplasms. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Melanoma Research Alliance.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Melanomas display distinct transcriptomic states, but it remains unclear how they associate with clinical outcomes. We performed digital spatial RNA profiling (DSP-RNA) of metastatic tumors from patients to investigate how transcriptomic states correlate with melanoma specific survival (MSS) and acral melanoma (AM). We performed DSP-RNA across a tissue microarray constructed from 111 patients with in-transit metastatic melanoma (ITM) diagnosed from 1990 to 2020. Data quality control, noise correction, and normalization yielded high-quality profiles from 105 patients, including 30 (36%) who received immune checkpoint inhibitors and 20 (24%) with AM. We performed principal component (PC) analysis and correlated the results with published gene signatures: The PC1 axis differentiated transitory from undifferentiated melanoma, PC2 reflected immune cell infiltration, PC3 corresponded to stromal cells and neural crest–like melanoma, and PC4 associated with melanocytic melanoma. Across a cohort of treatment-naïve ITM, high expression of the melanocytic state conferred a median MSS difference of 7.72 years (melanocytic “high” = 5.16 years versus “low” = 12.88 years, log-rank P = 0.0061) and independently associated with poor survival in multivariate analysis. AMs showed higher melanocytic state gene expression compared to nonacral. Findings were validated in external datasets, supporting that the melanocytic state predicts poor prognosis. The melanocytic state is associated with poor prognosis and may be enriched in AM, implying that identifying patients with melanocytic melanoma may be important for therapeutic decisions. Unlike other gene expression predictors proposed for prognostic stratification, the melanocytic state characterizes a biological subtype, suggesting that it may have specific therapeutic vulnerabilities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaTranscriptomeMelanocytesSkin NeoplasmsHumansFemaleMalePrognosisGene Expression Regulation, NeoplasticNeoplasm MetastasisGene Expression ProfilingMiddle AgedBiomarkers, TumorAgedPrincipal Component Analysis

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA.
  • Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA.
  • Department of Surgery, Duke University, Durham, NC, USA.
  • Department of Dermatology, University North Carolina, at Chapel Hill, Chapel Hill, NC, USA.
  • University of Illinois College of Medicine, Chicago, IL, USA.
  • Department of Urology, University of Michigan, Ann Arbor, MI, USA.

ORCID-Profile: Ziyin Huang, Kristen E Rhodin, Rami Al-Rohil, Viviana Geron, Arul M Chinnaiyan, Margaret H O'Connor, Christina V Angeles, Smita K Nair, Matthew K Iyer, Georgia M Beasley

Förderung

  • Melanoma Research Alliance

Zitieren

APA

Huang, Z., Rhodin, K. E., Al-Rohil, R., Geron, V., Chinnaiyan, A. M., O'Connor, M. H., Angeles, C. V., Nair, S. K., Iyer, M. K., & Beasley, G. M. (2026). The melanocytic transcriptomic state is independently associated with poor overall survival in patients with metastatic melanoma. Science Advances, 12(30). https://doi.org/10.1126/sciadv.aec7394

Vancouver

Huang Z, Rhodin KE, Al-Rohil R, Geron V, Chinnaiyan AM, O'Connor MH, et al. The melanocytic transcriptomic state is independently associated with poor overall survival in patients with metastatic melanoma. Science Advances. 2026;12(30). doi:10.1126/sciadv.aec7394

BibTeX
@article{Huang2026,
  author = {Huang, Ziyin and Rhodin, Kristen E and Al-Rohil, Rami and Geron, Viviana and Chinnaiyan, Arul M and O'Connor, Margaret H and Angeles, Christina V and Nair, Smita K and Iyer, Matthew K and Beasley, Georgia M},
  title = {The melanocytic transcriptomic state is independently associated with poor overall survival in patients with metastatic melanoma},
  journal = {Science Advances},
  year = {2026},
  volume = {12},
  number = {30},
  doi = {10.1126/sciadv.aec7394}
}
Kostenlos starten →